February 1997 - The CenterWatch Monthly : Volume 4, Issue 1, February 1997
Product Details
Taking the Measure of CROs
Investigative sites rate the best and worst CROs to work with
Sites name Covance as the CRO that, in general works best with investigators
Survey reveals specific steps CROs can take to curry favor with sites
The survey also identifies specific, common problems in site-CRO relationships
Reaching Out to Minority Investigators
A former Abbott manager is building a network of investigators that practice primarily in minority communities
Eli Lilly plans to pilot a program with the group
The Strange Case of Dr. Burzynski
Investigator has been battling FDA for the past 13 years over his use of an unapproved cancer treatment
The treatment -- antineoplastons -- has received strong support from Buryznski's patients
The FDA has been unable to curtail Burzynski's use of antineoplaston therapy on his patients; FDA is now bringing him to trial on charges of mail fraud and violation of interstate shipping laws
An Interview with Judith Hardardt
President and founder of The Hardardt group discusses building and selling a CRO
- Grant Leads